STOCK TITAN

abrdn Healthcare Opportunities Fund (THQ) SEC Filings

THQ NYSE
Rhea-AI Summary

abrdn Healthcare Opportunities Fund director Chris LaVictoire Mahai purchased 568 shares of Common Stock on July 16, 2026 at $18.49 per share, bringing direct holdings to 568 shares. The trade is reported as a purchase in an open market or private transaction and is not marked as pursuant to a Rule 10b5-1 trading plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.85%
Tags
insider
-
Rhea-AI Summary

abrdn Healthcare Opportunities Fund director Mahai Chris LaVictoire has filed an initial Form 3, which identifies him as a director of the fund. The filing reports no purchases, sales, gifts, derivative exercises, or other transactions, and shows no derivative positions or holding entries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
insider
-
Rhea-AI Summary

abrdn Healthcare Opportunities Fund filed an initial ownership report for a company officer. The reporting person is identified as a Vice President of the fund and is filing individually. In the explanatory section, the report states that no securities are beneficially owned by this officer as of the event date of 12/09/2025. A power of attorney is noted as Exhibit 24, authorizing the signatory to sign on behalf of the reporting person.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.11%
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.19%
Tags
insider

FAQ

How many abrdn Healthcare Opportunities Fund (THQ) SEC filings are available on StockTitan?

StockTitan tracks 4 SEC filings for abrdn Healthcare Opportunities Fund (THQ). Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for abrdn Healthcare Opportunities Fund (THQ)?

The most recent SEC filing for abrdn Healthcare Opportunities Fund (THQ) was filed on July 20, 2026.